Central Pharmaceutical JSC No3 - ESG Rating & Company Profile powered by AI
The SDG score for Central Pharmaceutical JSC No3 represents its transparency towards the United Nations Sustainable Development Goals. Complete Sustainability analysis of Central Pharmaceutical JSC No3 are reached by signing up for free. If you are employed by Central Pharmaceutical JSC No3 and you would like to use your ESG rating, please contact us.
Central Pharmaceutical JSC No3 in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Central Pharmaceutical JSC No3 | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Central Pharmaceutical JSC No3 have an accelerator or VC vehicle to help deliver innovation?
Does Central Pharmaceutical JSC No3 disclose current and historical energy intensity?
Does Central Pharmaceutical JSC No3 report the average age of the workforce?
Does Central Pharmaceutical JSC No3 reference operational or capital allocation in relation to climate change?
Does Central Pharmaceutical JSC No3 disclose its ethnicity pay gap?
Does Central Pharmaceutical JSC No3 disclose cybersecurity risks?
Does Central Pharmaceutical JSC No3 offer flexible work?
Does Central Pharmaceutical JSC No3 have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Central Pharmaceutical JSC No3 disclose the number of employees in R&D functions?
Does Central Pharmaceutical JSC No3 conduct supply chain audits?
Does Central Pharmaceutical JSC No3 disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Central Pharmaceutical JSC No3 conduct 360 degree staff reviews?
Does Central Pharmaceutical JSC No3 disclose the individual responsible for D&I?
Does Central Pharmaceutical JSC No3 disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Central Pharmaceutical JSC No3 disclose current and / or historical scope 2 emissions?
Does Central Pharmaceutical JSC No3 disclose water use targets?
Does Central Pharmaceutical JSC No3 have careers partnerships with academic institutions?
Did Central Pharmaceutical JSC No3 have a product recall in the last two years?
Does Central Pharmaceutical JSC No3 disclose incidents of discrimination?
Does Central Pharmaceutical JSC No3 allow for Work Councils/Collective Agreements to be formed?
Has Central Pharmaceutical JSC No3 issued a profit warning in the past 24 months?
Does Central Pharmaceutical JSC No3 disclose parental leave metrics?
Does Central Pharmaceutical JSC No3 disclose climate scenario or pathway analysis?
Does Central Pharmaceutical JSC No3 disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Central Pharmaceutical JSC No3 disclose the pay ratio of women to men?
Does Central Pharmaceutical JSC No3 support suppliers with sustainability related research and development?
Does Central Pharmaceutical JSC No3 disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Central Pharmaceutical JSC No3 reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Central Pharmaceutical JSC No3 involved in embryonic stem cell research?
Does Central Pharmaceutical JSC No3 disclose GHG and Air Emissions intensity?
Does Central Pharmaceutical JSC No3 disclose its waste policy?
Does Central Pharmaceutical JSC No3 report according to TCFD requirements?
Does Central Pharmaceutical JSC No3 disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Central Pharmaceutical JSC No3 disclose energy use targets?
Does Central Pharmaceutical JSC No3 disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Central Pharmaceutical JSC No3 have a policy relating to cyber security?
Have a different question?
Potential Risks for Central Pharmaceutical JSC No3
These potential risks are based on the size, segment and geographies of the company.